Endoscope Sterilization Market size was around USD 1.4 billion in 2026 and is slated to grow at a 9.16% CAGR from 2027 to 2036, surpassing USD 3.36 billion by 2036. The industry revenue for 2027 is calculated at USD 1.51 billion.
The endoscope sterilization market is gaining momentum as healthcare facilities place greater emphasis on preventing healthcare-associated infections linked to inadequate or inconsistent device reprocessing. Endoscopes are complex instruments with narrow channels and intricate surfaces that can retain biological contaminants when cleaning and sterilization procedures are not sufficiently effective. This is increasing the need for advanced sterilization systems that provide more reliable microbial inactivation while supporting standardized reprocessing protocols. Hospitals and ambulatory care facilities are also strengthening infection prevention practices, encouraging investments in equipment that can improve the consistency, traceability, and safety of endoscope decontamination workflows.
The growing use of robotic and flexible endoscopic procedures is creating additional demand for specialized reprocessing capabilities, as these instruments often involve sophisticated designs and components that require carefully controlled cleaning and sterilization processes. Increasing procedural adoption is encouraging healthcare providers to establish more precise workflows capable of addressing complex instrument geometries while minimizing the risk of damage to sensitive components. Advanced sterilization systems can support controlled exposure conditions and repeatable processing, helping facilities manage the growing volume and variety of reusable endoscopic equipment while maintaining stringent infection control requirements.
Hospitals are increasingly evaluating low-temperature sterilization technologies to handle heat-sensitive endoscopic instruments without compromising equipment integrity, supporting growth in the endoscope sterilization market. Conventional high-temperature approaches may not be suitable for certain flexible scopes and associated components, creating demand for sterilization methods that operate under gentler thermal conditions. These technologies can enable healthcare facilities to integrate sensitive devices into more efficient reprocessing workflows while reducing concerns related to heat-induced deterioration. As hospitals seek to improve equipment utilization, streamline turnaround times, and strengthen reprocessing capacity, low-temperature systems are becoming increasingly relevant for modern endoscopy departments.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising healthcare-associated infections driving demand for advanced endoscope sterilization systems | 2.40% | High | North America, Europe | High | Near Term |
| Growth in robotic and flexible endoscopy increasing need for precision sterilization workflows | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Increasing hospital investments in low-temperature sterilization technologies improving endoscope reprocessing efficiency | 1.80% | High | Asia Pacific, Europe | Medium | Mid Term |
North America held the largest share of the endoscope sterilization market, accounting for 36.51% in 2026, supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong emphasis on infection prevention. Healthcare facilities in the region increasingly prioritize stringent sterilization protocols to reduce the risk of healthcare-associated infections, creating sustained demand for reliable and efficient endoscope reprocessing solutions. Ongoing investments in hospital infrastructure and the adoption of advanced sterilization technologies are further strengthening the regional market.
Asia Pacific is anticipated to be the fastest-growing region, driven by expanding healthcare infrastructure, increasing adoption of endoscopic procedures, and growing awareness of infection control practices. Improvements in hospital capacity and greater attention to patient safety are encouraging healthcare providers to strengthen instrument reprocessing capabilities. Rising healthcare expenditure and the gradual modernization of medical facilities are also supporting the adoption of more sophisticated endoscope sterilization systems across the region.
The U.S. endoscope sterilization market focuses on strengthening infection prevention through automated reprocessing systems and strict compliance with clinical protocols. Healthcare facilities across the U.S. continue investing in technologies that improve sterilization consistency, workflow efficiency, and patient safety.
Japan continues enhancing endoscope sterilization processes to support high procedural volumes while maintaining stringent hygiene standards. Healthcare providers in Japan emphasize reliable automated systems that optimize turnaround times without compromising sterilization quality.
South Korea is expanding use of automated endoscope sterilization equipment as hospitals modernize infection control practices. Medical facilities in South Korea increasingly seek integrated solutions that improve operational consistency, equipment monitoring, and regulatory compliance.
Germany prioritizes endoscope sterilization systems that meet rigorous healthcare quality and regulatory requirements. Hospitals in Germany increasingly adopt automated reprocessing technologies that improve documentation, operational efficiency, and standardized infection control practices.
France emphasizes endoscope sterilization technologies that strengthen hospital hygiene programs and support standardized reprocessing procedures. Healthcare providers in France prioritize equipment that enhances workflow reliability while reducing manual intervention throughout sterilization cycles.
Italy continues upgrading endoscope sterilization capabilities to improve procedural efficiency and infection control across healthcare facilities. Hospitals in Italy increasingly value dependable automated reprocessing systems that support consistent sterilization performance and effective equipment utilization.
Flexible endoscopes held the largest and fastest-growing position in the endoscope sterilization market, accounting for 75.21% in 2026, driven by their extensive use across minimally invasive diagnostic and therapeutic procedures and the critical need for reliable reprocessing between uses. Their complex structures, including narrow channels and intricate surfaces, require carefully controlled sterilization and disinfection processes to minimize contamination risks and maintain patient safety. The expanding use of minimally invasive procedures is increasing the volume of flexible endoscopes requiring appropriate reprocessing, while healthcare facilities are placing greater emphasis on standardized infection-control practices. These factors are supporting sustained demand for specialized sterilization solutions capable of addressing the operational and safety requirements associated with flexible endoscopes.
Sterilizers represented the largest share of the endoscope sterilization market, accounting for 44.1% in 2026, reflecting their fundamental role in maintaining infection-control standards and supporting the safe reuse of medical instruments. Healthcare facilities require dependable sterilization equipment to ensure that reusable devices are appropriately processed before subsequent procedures. Increasing awareness of healthcare-associated infection prevention and the need for consistent reprocessing protocols are reinforcing demand for reliable sterilization systems. Their established role within medical instrument processing workflows provides sterilizers with a strong position as healthcare providers continue to prioritize patient safety and procedural hygiene.
Automated endoscope reprocessors (AERs) are expected to register the fastest growth as healthcare facilities increasingly seek automated, standardized, and reproducible approaches to endoscope reprocessing. AERs can reduce reliance on manual handling while helping healthcare personnel follow consistent cleaning and disinfection procedures. The growing focus on infection prevention, workflow efficiency, and traceable reprocessing practices is encouraging facilities to adopt automated technologies. As endoscopy volumes expand and healthcare providers seek to improve operational consistency while reducing potential variability in manual processes, AERs are gaining importance within modern endoscope reprocessing environments.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Type | Flexible Endoscopes, Rigid Endoscopes | Flexible Endoscopes | Flexible Endoscopes |
| Product | Sterilizers, Liquid Chemical Sterilization Systems, Automated Endoscope Reprocessors (AERs) | Sterilizers | Automated Endoscope Reprocessors (AERs) |
| Device Type | Colonoscopes, Bronchoscopes, Duodenoscopes, Others | Colonoscopes | Duodenoscopes |
1. STERIS Corporation (USA)
2. Getinge AB (Sweden)
3. Advanced Sterilization Products (Fortive Corporation) (USA)
4. Steelco S.p.A. (Italy)
5. Nanosonics Limited (Australia)
6. Ecolab Inc. (USA)
7. Tuttnauer (Israel)
8. Olympus Corporation (Japan)
9. Cantel Medical Corporation (USA)
The endoscope sterilization market is evolving as healthcare providers prioritize infection prevention and stricter sterilization standards. Advanced automated sterilization systems with improved cycle efficiency and contamination tracking capabilities are gaining traction in clinical environments. Increased focus on patient safety and workflow optimization is also encouraging the adoption of technologically advanced reprocessing solutions.
| Company Name | Date | Key Development |
|---|---|---|
| Olympus | Sep-24 | Olympus announced launch of Sapphire, its first flexible endoscope sterilization facility in Australia under the Olympus On-Demand solution. The initiative establishes a managed sterilization service for Australian healthcare providers, aimed at reducing operational complexity, costs, and infection control risks associated with endoscopy reprocessing while expanding Olympus’s service-based footprint in the region. |
| PENTAX Medical | Aug-24 | PENTAX Medical, HOYA Group, received FDA clearance for its DEC Duodenoscope to be compatible with Advanced Sterilization Products’ STERRAD 100NX system. The clearance expands interoperability between endoscopy and low-temperature sterilization technologies, strengthening adoption pathways for hydrogen peroxide sterilization systems and reinforcing ecosystem integration across device and sterilization platform providers. |
| Olympus Medical Systems Corporation | Jan-23 | FDA CDRH issued warning letters to Olympus Medical Systems Corporation and its subsidiary Aizu Olympus following inspections identifying violations of medical device reporting and quality system regulations affecting endoscopes and automated endoscope reprocessors. The findings highlight regulatory compliance risks across Olympus’s endoscopy portfolio and potential operational and manufacturing oversight implications. |